- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Iliopsoas.
Displaying page 1 of 1.
EudraCT Number: 2018-000089-12 | Sponsor Protocol Number: HIP/FUSION#4 | Start Date*: 2018-04-24 | |||||||||||
Sponsor Name:Institut for Klinisk Medicin, Aarhus Universitet | |||||||||||||
Full Title: Effect and safety of the iliopsoas plane block in healthy volunteers | |||||||||||||
Medical condition: No specific medical condition is investigated. The objective of the trial is to investigate a method for postoperative analgesia after elective hip surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005838-15 | Sponsor Protocol Number: 01-10122020 | Start Date*: 2021-03-22 | |||||||||||
Sponsor Name:Aarhus University Hospiotal | |||||||||||||
Full Title: The effect of iliopsoas plane block on opioid consumption and pain after hip arthroscopy A double-blind randomized, controlled trial | |||||||||||||
Medical condition: Postoperative pain after hip arthroscopy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2024-000461-24 | Sponsor Protocol Number: LPS15677 | Start Date*: 2024-12-18 |
Sponsor Name:Genzyme | ||
Full Title: A Single Arm, Prospective, Open-label, Multi-center Study to Evaluate Efficacy and Safety in Chinese Patients with Late Onset Pompe Disease with One Year Alglucosidase Alfa Treatment | ||
Medical condition: Pompe's disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2021-004110-20 | Sponsor Protocol Number: 78666 | Start Date*: 2022-10-12 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Improving symptomatic treatment with pyridostigmine and amifampridine: a randomized double-blinded, placebo controlled crossover trial in patients with myasthenia gravis (IMPACT-MG) | |||||||||||||
Medical condition: Myasthenia Gravis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
